GNH USA

Europe — EMA

Nitrazepam Genethics Europe

GNH USA supplies Nitrazepam Genethics Europe (Nitrazepam), a benzodiazepine for insomnia, anxiety and seizure disorders. Request a quote for global supply.

Nitrazepam

Request sourcing

1
Pack/s

What is Nitrazepam?

Nitrazepam, the active ingredient in Nitrazepam Genethics Europe, is a benzodiazepine presented as a tablet for oral use. It acts as an anxiolytic, sedative‑hypnotic and anticonvulsant, and is prescribed for insomnia, anxiety disorders, and seizure disorders in adult patients, and when appropriate, in elderly patients under careful monitoring.

GNH USA supplies Nitrazepam Genethics Europe as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to stringent quality standards and regulatory requirements. The company serves hospitals, pharmacies and clinics worldwide, providing reliable sourcing and logistics support for this prescription‑only medication.

What is Nitrazepam used for?

Nitrazepam, a benzodiazepine that enhances GABA‑A receptor activity, is used for several central nervous system conditions.

- Insomnia: helps initiate and maintain sleep in patients with difficulty sleeping. - Anxiety disorders: reduces excessive worry and tension, facilitating calmer mental states. - Seizure disorders: provides anticonvulsant control for certain types of epileptic seizures.

What are the side effects of Nitrazepam?

Nitrazepam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness - Fatigue - Dizziness - Impaired coordination

Serious or Rare Side Effects: - Respiratory depression, especially when combined with other depressants - Severe allergic reactions such as rash, swelling, or anaphylaxis - Development of dependence, tolerance, or withdrawal symptoms upon discontinuation

What precautions apply to Nitrazepam?

When prescribing nitrazepam, clinicians should consider several safety measures.

- Dose adjustment in elderly: start with the lowest effective dose and monitor for excessive sedation. - Avoid abrupt discontinuation: taper gradually under medical supervision to prevent withdrawal. - Caution in hepatic impairment: reduced metabolic clearance may require dose reduction. - Avoid use with other CNS depressants: concurrent alcohol, opioids, or sedatives increase sedation risk. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store below 25°C: keep in the original container, protect from moisture and light.

What does Nitrazepam interact with?

Nitrazepam can interact with various medicines, influencing its safety profile.

Major Interactions (Avoid): - Other benzodiazepines: additive central nervous system depression. - Opioids: heightened risk of respiratory depression and profound sedation. - Alcohol: synergistic sedative effects that may impair respiration.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may increase overall sedation. - Antihistamines: can enhance drowsiness and impair coordination. - CYP3A4 inhibitors (e.g., ketoconazole): may raise nitrazepam plasma concentrations, requiring dose adjustment.

Frequently asked questions

What is Nitrazepam Genethics Europe used for?+
Nitrazepam Genethics Europe is a prescription‑only benzodiazepine used to manage insomnia, anxiety disorders, and certain seizure disorders. It works by enhancing the inhibitory action of GABA in the brain, helping to promote sleep, reduce excessive worry, and control convulsive activity in appropriate patients.
How does nitrazepam work in the body?+
Nitrazepam binds to a specific site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride channel opening when GABA binds, leading to greater neuronal inhibition and producing its anxiolytic, sedative‑hypnotic, and anticonvulsant effects.
What is the usual dose of nitrazepam?+
The exact dose of nitrazepam is determined by the prescribing clinician based on the individual’s medical condition, age, liver function, and response to therapy. Dosage regimens are tailored to each patient and should follow the prescriber’s instructions without deviation.
Is nitrazepam safe during pregnancy or breastfeeding?+
The safety of nitrazepam in pregnancy and lactation has not been established. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Nitrazepam Genethics Europe from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.
How does nitrazepam compare with other benzodiazepines?+
Nitrazepam shares the core mechanism of GABA‑A modulation with other benzodiazepines but is distinguished by its relatively long half‑life, which can provide sustained sleep‑inducing effects. Compared with shorter‑acting agents, it may be preferred for chronic insomnia but requires careful monitoring for accumulation and daytime sedation.
What are the recommended storage conditions for nitrazepam tablets?+
Nitrazepam tablets should be stored at temperatures below 25 °C, in their original packaging, protected from moisture and light. Maintaining a stable environment helps preserve potency and prevents degradation over the product’s shelf life.
How is nitrazepam administered?+
Nitrazepam is administered orally, typically as a tablet taken with a glass of water. The exact timing (e.g., before bedtime for insomnia) and dosing schedule are determined by the prescriber based on the therapeutic indication and patient needs.
What are the most serious risks associated with nitrazepam?+
Serious risks include respiratory depression, especially when combined with other depressants, severe allergic reactions, and the potential for dependence, tolerance, or withdrawal symptoms upon abrupt discontinuation. Patients should be monitored closely for these events, and any concerning signs should prompt immediate medical evaluation.
Who should not use nitrazepam?+
Nitrazepam is contraindicated in individuals with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, and in patients who are currently abusing alcohol or other central nervous system depressants. It should also be used with caution in those with severe hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nitrazepam
Route
Oral Use
Manufacturer
Genethics Europe Limited
Origin
EU

Related products

Mogadon 5 mg

Mogadon 5 mg

Nitrazepam · 5 MG

Mogadon
TABLET
AA PHARMA INC
CANADA
Mogadon 10 mg

Mogadon 10 mg

Nitrazepam · 10 MG

Mogadon
TABLET
AA PHARMA INC
CANADA
Apodorm

Apodorm

Nitrazepam

Actavis Group Ptc Ehf.
EU
Cerson

Cerson

Nitrazepam

Belupo D.D.
EU